QTMeds

Drug Database Monograph

BIMZELX 160 mg

PENDING REVIEW

Active Ingredient: BIMEKIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 68708415

← Back to Prescription Analyzer